Kinnate Biopharma
KNTE
$2.65
Share price
0.00%
Change (1 day)
-18.71%
Change (1 year)
Categories
Kinnate Biopharma (KNTE) - Net assets
Net assets on the balance sheet as of December 2023 : $0.15 B
According to Kinnate Biopharma's latest financial reports the company has $0.15 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Kinnate Biopharma - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.25 B | -27.08% |
| 2021-12-31 | $0.35 B | -9.86% |
| 2020-12-31 | $0.39 B | -2349.04% |
| 2019-12-31 | $-17.49 M | -329.78% |
| 2018-12-31 | $7.61 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.32 B | 106.27% | 🇺🇸 USA |